Search Results - O. A. Rubanenko

Refine Results
  1. 1

    Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease by O. A. Rubanenko

    Published 2015-11-01

    Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF) development after coronary artery bypass graft (CABG) surgery in patients with ischemic heart disease (IHD) with the assessment of inflammation, sheer stress and myocardial injury indicators. Material and...

    Full description

    Get full text
    Article
  2. 2

    The Influence of Multivessel Bypass Surgery on the Onset of Atrial Fibrillation in Elderly Patients by O. A. Rubanenko, A. O. Rubanenko

    Published 2022-05-01

    Aim. To study the factors associated with the development of postoperative atrial fibrillation (POAF) with single- or two- or more vascular bypass grafting in elderly patients with coronary heart disease.Methods. The study included 454 patients with coronary artery disease who underwent CABG. Patien...

    Full description

    Get full text
    Article
  3. 3

    ATRIAL FIBRILLATION IN CARDIOVASCULAR INTERVENTIONS IN ON-PUMP AND OFF-PUMP REGIMENS by O. A. Rubanenko, O. V. Fatenkov, S. M. Khokhlunov

    Published 2015-11-01

    Aim. To evaluate the prevalence of post-operation atrial fibrillation (POAF) in coronary artery bypass (CBG) on-pump or off-pump regimens.Material and methods. Totally, 469 patients studied with ischemic heart disease admitted for CBG (389 patients, 77% — males, mean age — 61,1±8,0 y.) had onpump CB...

    Full description

    Get full text
    Article
  4. 4

    D-dimer as a risk factor for cardiovascular events in patients with liver diseases by O. A. Rubanenko, I. A. Zolotovskaya, P. R. Shatskaya

    Published 2025-04-01

    The relationship between cardiovascular and liver diseases is a significant clinical problem; since diseases of one system can aggravate the other. One of the key markers for cardiovascular risk assessment in patients with liver diseases is D-dimer. This is a fibrin degradation product; the level of...

    Full description

    Get full text
    Article
  5. 5

    Omega-3 polyunsaturated fatty acids in the prevention of postoperative atrial fibrillation in open heart surgery: a systematic review and meta-analysis by O. A. Rubanenko, A. O. Rubanenko, I. L. Davydkin

    Published 2023-03-01

    Aim. To evaluate the literature data on the efficacy of omega-3 polyunsaturated fatty acids (PUFAs) in the prevention of postoperative atrial fibrillation (POAF) in elective cardiac surgery, including onor off-pump coronary artery bypass grafting and/or valve replacement and/or repair.Material and m...

    Full description

    Get full text
    Article
  6. 6

    POLYMORPHISM OF THE INTERLEUKIN-6, INTERLEUKIN-10, SUPEROXIDE DISMUTASE AND ANGIOTENSIN CONVERTING ENZYME GENES, AND THE RISK OF ATRIAL FIBRILLATION AFTER CARDIOSURGERY by O. A. Rubanenko, O. V. Fatenkov, S. M. Khokhlunov, S. A. Shavkunov

    Published 2016-10-01

    Aim. To reveal the relation of gene polymorphisms of interleukin-6 (IL6, C174G), interleukin-10 (IL10, C592A), superoxide dismutase (SOD1, G8958A) and angiotensin converting enzyme (ACE, Alu Ins/Del) with postsurgery atrial fibrillation (PSAF) after coronary bypass grafting (CBG) in coronary heart d...

    Full description

    Get full text
    Article
  7. 7

    Efficacy and safety of acetazolamide in patients with NYHA class II-IV decompensated heart failure: protocol of an open-label prospective randomized multicenter study (ORION-A) by O. A. Rubanenko, A. O. Rubanenko, S. V. Villevalde, D. V. Duplyakov

    Published 2023-09-01

    Aim. To study the efficacy and safety of acetazolamide administered orally to patients with decompensated heart failure (HF) at the hospital stage within 72 hours from admission, compared with standard therapy.Material and methods. This open-label, prospective, randomized, multicenter study is plann...

    Full description

    Get full text
    Article
  8. 8

    A ROLE OF SUPEROXIDE DISMUTASE IN DEVELOPMENT OF POST-OPERATION ATRIAL FIBRILLATION IN CORONARY HEART DISEASE PATIENTS by O. A. Rubanenko, O. V. Fatenkov, S. M. Khokhlunov, L. V. Limareva

    Published 2017-03-01

    Aim. To evaluate the level of superoxide dismutase (SOD) in coronary heart disease (CHD) patients underwent coronary bypass  (CBG), and to estimate  its importance in development of post-surgery atrial fibrillation (PSAF).Material and methods. Totally, 96 patients studied,  with CHD, admitted for CB...

    Full description

    Get full text
    Article
  9. 9

    Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients by A. O. Rubanenko, O. A. Rubanenko, L. V. Limareva, Iu. V. Shchukin

    Published 2018-11-01

    Aim. The aim of the study was to assess the association of genetic polymorphisms of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) with atrial fibrillation development in elderly patients with coronary artery disease (CAD), undergoing coronary artery b...

    Full description

    Get full text
    Article
  10. 10

    Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER by I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk

    Published 2022-07-01

    Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who underwent COVID-19.Material and methods. Hypertensive patients with dyslipidemia who underwent COVID-19 [n=126; 58 men and 68 women; median age 60 (56.0; 65.5) years] examined. Patients were included into...

    Full description

    Get full text
    Article
  11. 11

    Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin’s Lymphomas in the Course of Programmatic Antitumor Therapy by G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, O. A. Rubanenko, T. Y. Stepanova

    Published 2024-04-01

    Цель исследования. Изучить ассоциацию клинико-диагностических показателей кардиоваскулярной токсичности у пациентов с неходжкинскими лимфомами, находящихся в процессе программной противоопухолевой иммунохимиотерапии.Материалы и методы. Проспективно было отобрано 72 пациента с подтвержденным диагнозо...

    Full description

    Get full text
    Article
  12. 12

    The impact of telemedicine technologies on the quality of life of patients with heart failure: a systematic review and meta-analysis by A. A. Garanin, A. O. Rubanenko, Yu. A. Trusov, O. A. Rubanenko, J. V. Djinibalaeva

    Published 2025-05-01

    Aim. To study the literature data and evaluate the telemonitoring results in patients with heart failure to determine their impact on the quality of life.Material and methods. We searched information according to PRISMA require­ments using the following databases: PubMed, Embase, Crossref, MedLine,...

    Full description

    Get full text
    Article
  13. 13

    Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery by O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin

    Published 2022-03-01

    Aim. To estimate the role of omega-3 polyunsaturated fatty acids (PUFAs) administration in atrial fibrillation (AF) prevention after planned coronary artery bypass graft (CABG) surgery.Material and Methods. Studied were 306 patients divided into two groups: patients of group I didn’t receive PUFAs (...

    Full description

    Get full text
    Article
  14. 14

    Gender cardiology: clinical and pathophysiological features of the course the main diseases in women by I. L. Davydkin, V. P. Kuzmin, I. A. Zolotovskaya, R. K. Hayretdinov, S. P. Krivova, O. A. Rubanenko

    Published 2024-05-01

    Coronary heart disease is the leading cause of death for both women and men. Older women, when coronary heart disease first appears, have more comorbidities and usually complain of atypical symptoms. Mortality and hospitalization rates caused by acute myocardial infarction are higher for women. It s...

    Full description

    Get full text
    Article
  15. 15

    Clinical, echocardiographic parameters and markers of oxidative stress associated with atrial fibrillation in patients undergoing coronary artery bypass graft surgery by O. A. Rubanenko, A. O. Rubanenko, Yu. V. Shchukin, L. V. Limareva, V. V. Bogush, M. N. Milyakova

    Published 2020-08-01

    Aim. To estimate the association of clinical, echocardiographic parameters and markers of oxidative stress with postoperative atrial fibrillation (POAF) in patients with coronary artery disease (CAD) undergoing coronary artery bypass graft (CABG) surgery.Material and methods. This case-control study...

    Full description

    Get full text
    Article
  16. 16

    Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease by E. G. Skorodumova, O. A. Rubanenko, A. O. Rubanenko, S. T. Enginoev, M. A. Kercheva, E. L. Zaslavskaya, E. V. Efremova, E. Yu. Gubareva, I. N. Lyapina, R. M. Velieva, E. A. Skorodumova, A. V. Siverina

    Published 2024-04-01

    Aim. To compare the effectiveness and safety of direct oral anticoagulants (DOACs) with a vitamin K antagonist (VKA) in patients with atrial fibrillation (AF) and stage 4 and 5 chronic kidney disease (CKD).Material and methods. We searched in the PubMed, Google Scholar, and Web of Science databases...

    Full description

    Get full text
    Article
  17. 17
  18. 18

    Peculiarities of polyvascular disease and the diagnostic significance of the ankle-brachial index in patients with coronary artery disease: results from the real-world registry KAM... by G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, T. I. Batluk, N. A. Koziolova, A. I. Chesnikova, A. Y. Vaskin, D. S. Tokmin, I. G. Bakulin, O. L. Barbarash, N. U. Grigoryeva, I. V. Gubareva, N. V. Izmozherova, U. K. Kamilova, S. G. Kechedzhieva, Z. F. Kim, N. A. Koriagina, S. V. Mironova, N. P. Mitkovskaya, S. V. Nemirova, L. M. Nurieva, M. M. Petrova, E. A. Polyanskaya, A. P. Rebrov, A. V. Svarovskaya, E. A. Smirnova, A. B. Sugraliev, Y. B. Khovaeva, G. V. Shavkuta, I. I. Shaposhnik, M. Y. Alieva, A. B. Almukhanova, A. V. Aparkina, R. A. Bashkinov, L. N. Belousova, E. I. Blokhina, V. O. Bochkareva, M. V. Buianova, F. Y. Valikulova, A. D. Vende, A. S. Galyavich, V. V. Genkel, E. V. Gorbunova, E. D. Gordeychuk, E. A. Grigorenko, E. V. Grigoryeva, I. L. Davydkin, D. S. Evdokimov, A. N. Ermilova, S. B. Zhangelova, N. V. Zhdankina, E. I. Zheleznyak, N. S. Ilyanok, D. A. Kapsultanova, N. A. Karoli, E. A. Kartashova, A. S. Kuznetsova, A. T. Kumaritova, N. A. Magdeeva, S. A. Makarov, E. S. Melnikov, M. V. Novikova, I. A. Obukhova, E. V. Ponomarenko, A. O. Rubanenko, O. A. Rubanenko, F. E. Rustamova, V. A. Safronenko, E. I. Suchkova, A. I. Sycheva, D. R. Tagaeva, M. A. Trubnikova, T. P. Trunina, A. G. Frolov, V. V. Khatlamadzhiyan, Y. I. Khokhlova, A. I. Chernyavina, O. Y. Chizhova, M. A. Shambatov, T. V. Shnyukova, Y. V. Shchukin

    Published 2024-05-01

    Aim. To investigate the prevalence and characteristics of polyvascular disease in the Eurasian region's population with one or more previously established locations of atherosclerotic arterial damage, and to evaluate the diagnostic importance of the ankle-brachial index (ABI) as a marker for po...

    Full description

    Get full text
    Article
  19. 19

    Real-world data on managing patients with coronary artery disease and multifocal atherosclerosis. Results of the 12-month international clinical registry of patients with identifie... by G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, T. I. Batluk, N. A. Koziolova, A. I. Chesnikova, A. Y. Vaskin, D. S. Tokmin, I. G. Bakulin, O. L. Barbarash, N. Y. Grigoryeva, I. V. Gubareva, N. V. Izmozherova, U. R. Kamilova, S. G. Kechedzhieva, Z. F. Kim, N. A. Koriagina, S. V. Mironova, N. P. Mitkovskaya, S. V. Nemirova, L. M. Nurieva, M. M. Petrova, E. A. Polyanskaya, A. P. Rebrov, A. V. Svarovskaya, E. A. Smirnova, A. B. Sugraliev, Y. B. Khovaeva, G. V. Shavkuta, I. I. Shaposhnik, G. T. Aimakhanova, M. Y. Alieva, A. B. Almukhanova, A. V. Aparkina, D. A. Akhmentaeva, R. A. Bashkinov, N. M. Bekisheva, L. N. Belousova, E. I. Blokhina, V. O. Bochkareva, M. V. Buianova, F. Y. Valikulova, A. D. Vende, A. S. Galyavich, V. V. Genkel, E. V. Gorbunova, E. D. Gordeychuk, E. A. Grigorenko, E. V. Grigoryeva, G. M. Dabylova, I. L. Davydkin, D. S. Evdokimov, A. N. Ermilova, S. B. Zhangelova, N. V. Zhdankina, E. I. Zheleznyak, N. S. Ilyanok, D. A. Kapsultanova, N. A. Karoli, E. A. Kartashova, A. S. Kuznetsova, A. T. Kumaritova, N. A. Magdeeva, S. A. Makarov, O. A. Mamadaliev, E. S. Melnikov, N. J. Musrepov, R. Ya. Namatova, M. V. Novikova, I. A. Obukhova, E. V. Ponomarenko, A. O. Rubanenko, O. A. Rubanenko, V. A. Safronenko, E. I. Suchkova, A. I. Sycheva, D. R. Tagaeva, M. A. Trubnikova, T. P. Trunina, S. A. Tynalieva, A. G. Frolov, V. V. Khatlamadzhiyan, Y. I. Khokhlova, A. I. Chernyavina, O. Y. Chizhova, M. A. Shambatov, T. V. Shnyukova, Y. V. Shchukin

    Published 2025-04-01

    Aim. To study real-world data on managing patients with coronary artery disease (CAD) and multifocal atherosclerosis (MFA) for 12 months by outpatient cardiologists.Material and methods. KAMMA is a real-world registry organized by the Eurasian Association of Therapists. The main branch included men...

    Full description

    Get full text
    Article
  20. 20

    Analysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease) by M. M. Batyushin, M. A. Trubnikova, G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, S. Sh. Akhmedkhanov, I. G. Bakulin, I. A. Bodrievskaya, I. A. Viktorova, N. G. Vinogradova, A. S. Galyavich, N. P. Garganeeva, N. Yu. Grigorieva, S. B. Erofeeva, M. A. Kercheva, S. G. Kechedzhieva, N. A. Koryagina, S. V. Malchikova, V. A. Nevzorova, S. V. Nedogoda, M. M. Petrova, V. A. Pogrebetskaya, A. P. Rebrov, O. A. Rubanenko, E. A. Safianik, V. V. Skibitsky, E. A. Smirnova, E. A. Starovoitova, R. F. Khamitov, A. I. Chesnikova, T. M. Shabatina, I. I. Shaposhnik, A. R. Vaisberg, A. V. Aparkina, I. N. Barykina, T. I. Batluk, R. A. Bashkinov, A. T. Beybalayeva, Y. A. Belenikina, O. A. Bilevich, Zh. V. Bondareva, A. Yu. Vaskin, T. V. Vlasova, E. V. Galko, T. U. Garifullin, E. D. Gordeychuk, E. V. Grigorieva, I. V. Gubareva, L. K. Danilova, A. I. Dolgushina, E. M. Durygina, D. S. Evdokimov, N. V. Zhdankina, E. I. Zheleznyak, D. S. Zueva, D. S. Ivanova, E. Yu. Ivanchenko, M. V. Kazakovtseva, A. A. Kaznina, N. A. Karoli, D. S. Kaskaeva, Z. F. Kim, M. V. Kozlova, Y. I. Kudrinskaya, A. S. Kuznetsova, E. Yu. Levchenko, I. A. Lukonin, V. O. Lutova, N. A. Magdeeva, E. V. Makarova, N. E. Makarova, M. M. Mamontova, E. S. Melnikov, A. F. Molostvova, T. D. Naborshchikova, I. N. Nikitina, D. P. Novikova, M. V. Novikova, V. I. Pakusina, K. G. Pereverzeva, I. S. Pleshakov, Yu. G. Pokramovich, O. V. Ponomareva, E. A. Popova, N. A. Popova, E. S. Potapova, E. D. Resnyanskaya, M. Yu. Rozhkova, A. O. Rubanenko, M. D. Rudoy, A. S. Salasyuk, L. M. Salimova, V. I. Samokhina, N. Sh. Sanginova, F. I. Sattarova, A. Kh. Safina, D. P. Sirotenko, N. S. Skarzhinskaya, A. V. Skibitsky, E. I. Suchkova, L. E. Tepnadze, A. V. Fendrikova, T. E. Filatova, O. V. Filyushin, O. Yu. Chizhova, T. I. Chudinovskikh, S. S. Yakushin, E. M. Yashina

    Published 2024-08-01

    Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of markers (albuminuria (AU), decreased glomerular filtra...

    Full description

    Get full text
    Article